Profit Margin (Quarterly) Chart

View Profit Margin (Quarterly) for FLGT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Profit Margin (Quarterly) Chart
Start Trial

Historical Profit Margin (Quarterly) Data

View and export this data back to 2015. Start Trial.
Date Value
June 30, 2026 -34.80%
March 31, 2026 -35.53%
December 31, 2025 -28.38%
September 30, 2025 -8.12%
June 30, 2025 -23.54%
March 31, 2025 -16.20%
December 31, 2024 -8.12%
September 30, 2024 -20.48%
June 30, 2024 -12.80%
March 31, 2024 -21.47%
December 31, 2023 -190.5%
September 30, 2023 -15.90%
June 30, 2023 -17.08%
March 31, 2023 -23.95%
December 31, 2022 -35.56%
September 30, 2022 1.27%
June 30, 2022 8.86%
March 31, 2022 47.95%
December 31, 2021 41.20%
September 30, 2021 53.64%
June 30, 2021 49.42%
March 31, 2021 55.84%
Date Value
December 31, 2020 56.98%
September 30, 2020 45.85%
June 30, 2020 19.24%
March 31, 2020 -25.23%
December 31, 2019 -3.53%
September 30, 2019 14.13%
June 30, 2019 3.93%
March 31, 2019 -35.53%
December 31, 2018 -36.19%
September 30, 2018 -10.58%
June 30, 2018 -19.43%
March 31, 2018 -41.05%
December 31, 2017 -41.46%
September 30, 2017 -24.27%
June 30, 2017 -0.54%
March 31, 2017 4.37%
December 31, 2016 13.89%
September 30, 2016 -22.09%
June 30, 2016 -113.1%
March 31, 2016 -17.50%
December 31, 2015 -252.9%

Profit Margin Definition

Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.

Read full definition.

Profit Margin (Quarterly) Range, Past 5 Years

View Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Profit Margin (Quarterly) Benchmarks

View Profit Margin (Quarterly) Benchmarks
Start Trial
Quest Diagnostics, Inc. 10.94%
Labcorp Holdings, Inc. 8.02%
OPKO Health, Inc. -5.14%
Psychemedics Corp. --
NeoGenomics, Inc. 1.11%